Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones in NDMM and RRMM patients. NDMM, newly diagnosed multiple myeloma; RRMM, relapsed and/or refractory M

DataCite Commons2024-02-14 更新50

Transcriptome analysis of CHEK1 overexpression (AC or HC) VS control (A or H) and CHEK1 knockdown (AK_D or HK_D) VS control (AK or HK) in Mutiple Myeloma.

多发性骨髓瘤

CHEK1基因功能研究

Transcriptome sequencing was used to analyze changes in related signaling pathways and gene expression in Mutiple Myeloma cells when CHEK1 was overexptressed or knocked down. Examination of eight cel

NIAID Data Ecosystem30

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation. CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation

多发性骨髓瘤

骨病机制

To further determine how CST6 influence the myeloma bone disease. Overall design: scRNA sequencing were performed on bone marrow mononuclear cells from tumor bearing mice treated with and without CST6

NIAID Data Ecosystem100

Additional file 4 of Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria

消化道微生物组

多发性骨髓瘤

Additional file 4: Table S1. The strong Spearman’s correlation (Rho>0.5 & P<0.05) between the thirty most abundant genera was calculated in HC&MM samples (a), HC samples (b), and MM samp

Figshare2024-02-19 更新40

Pharmacological Downregulation of De Novo Active and Essential lncRNA SMILO via Inhibition of FLI1 Transcription Factor in Multiple Myeloma.

资源简介：

相关数据集